Ho JY et al.MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG/Ras/ERK signaling axis.Oncotarget 8:22443-22459 (2017).
Wang Q et al.Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin-1 from MMP-13-mediated proteolysis.Oncogene N/A:N/A (2014).
Cole CL et al.Ovarian cancer cell heparan sulfate 6-O-sulfotransferases regulate an angiogenic program induced by heparin-binding epidermal growth factor (EGF)-like growth factor/EGF receptor signaling.J Biol Chem 289:10488-501 (2014).
Li L et al.MEK1 promotes YAP and their interaction is critical for tumorigenesis in liver cancer.FEBS Lett 587:3921-7 (2013).
Li R et al.Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.J Biol Chem 287:15923-34 (2012).
Trejo CL et al.MEK1/2 inhibition elicits regression of autochthonous lung tumors induced by KRASG12D or BRAFV600E.Cancer Res 72:3048-59 (2012).
Huynh H et al.Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.Mol Cancer Ther 8:152-9 (2009).
Huynh H et al.Targeted inhibition of the extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) in the treatment of hepatocellular carcinoma.Mol Cancer Ther 6:138-46 (2007).